Compare DNTH & FFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNTH | FFIN |
|---|---|---|
| Founded | 2015 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.9B |
| IPO Year | 2018 | 1994 |
| Metric | DNTH | FFIN |
|---|---|---|
| Price | $95.71 | $34.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $121.00 | $36.50 |
| AVG Volume (30 Days) | ★ 1.2M | 929.7K |
| Earning Date | 05-06-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.39% |
| EPS Growth | N/A | ★ 13.46 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | $17.16 |
| Revenue Next Year | $29.48 | $6.61 |
| P/E Ratio | ★ N/A | $69.24 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.08 | $28.12 |
| 52 Week High | $102.33 | $38.74 |
| Indicator | DNTH | FFIN |
|---|---|---|
| Relative Strength Index (RSI) | 58.43 | 57.70 |
| Support Level | $79.27 | $31.30 |
| Resistance Level | $98.70 | $35.77 |
| Average True Range (ATR) | 5.37 | 0.75 |
| MACD | 0.83 | -0.04 |
| Stochastic Oscillator | 68.41 | 62.33 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.